Year To Quarter End Consolidated Statement Of Income

Perseus Proteomics Inc. - Filing #7246059

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
120,375,000 JPY
100,402,000 JPY
Cost of sales
16,324,000 JPY
12,717,000 JPY
Gross profit (loss)
104,051,000 JPY
87,685,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
930,481,000 JPY
982,415,000 JPY
Operating profit (loss)
-826,430,000 JPY
-894,729,000 JPY
Non-operating income
Interest income
1,951,000 JPY
46,000 JPY
Non-operating income
3,727,000 JPY
21,111,000 JPY
Non-operating expenses
Non-operating expenses
7,126,000 JPY
5,762,000 JPY
Ordinary profit (loss)
-829,829,000 JPY
-879,380,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
138,000 JPY
Extraordinary income
JPY
138,000 JPY
Extraordinary losses
Impairment losses
72,510,000 JPY
153,887,000 JPY
Extraordinary losses
72,510,000 JPY
223,290,000 JPY
Profit (loss) before income taxes
-902,340,000 JPY
-1,102,533,000 JPY
Income taxes - current
2,460,000 JPY
1,927,000 JPY
Income taxes
2,460,000 JPY
1,927,000 JPY
Profit (loss)
-904,800,000 JPY
-904,800,000 JPY
-904,800,000 JPY
-904,800,000 JPY
-1,104,460,000 JPY
-1,104,460,000 JPY
-1,104,460,000 JPY
-1,104,460,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.